Cargando…
Drug Utilization and Drug Pricing in the Private Primary Healthcare System in Malaysia: An Employer Price Control Mechanism
Uncontrolled drug pricing in the private healthcare system in Malaysia leads to high drug prices; however, its impact on employee drug utilization and employer reimbursement coverage is unclear. This study examined patterns of drug pricing and drug utilization among employees covered by employer med...
Autores principales: | Zin, Che Suraya, Taufek, Nor Hidayah, Bux, Siti Halimah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750386/ https://www.ncbi.nlm.nih.gov/pubmed/33365294 http://dx.doi.org/10.3389/fpubh.2020.551328 |
Ejemplares similares
-
Consumers' Knowledge, Attitudes, and Practices Toward Medicine Price Transparency at Private Healthcare Setting in Malaysia
por: Ahmad, Nur Sufiza, et al.
Publicado: (2021) -
Research on Nonsteroidal Anti-inflammatory Drugs in Malaysia: A Bibliometric Analysis
por: Zin, Che Suraya, et al.
Publicado: (2020) -
A Bibliometric Analysis of Opioid in Malaysia
por: Zin, Che Suraya, et al.
Publicado: (2020) -
Differential Patterns of Adherence to Opioid Therapy in Opioid Naïve and Opioid Existing Patients With Different Age Groups
por: Zin, Che Suraya, et al.
Publicado: (2019) -
The impact of drug shortages on drug prices: evidence from China
por: Hu, Shuchen, et al.
Publicado: (2023)